# Phase II Trial of RAD001 in Refractory Colorectal Cancer

> **NCT00337545** · PHASE2 · COMPLETED · sponsor: **Swedish Medical Center** · enrollment: 22 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** RAD001

## Key facts

- **NCT ID:** NCT00337545
- **Lead sponsor:** Swedish Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** —
- **Final completion:** 2007-04
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2007-10-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00337545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00337545, "Phase II Trial of RAD001 in Refractory Colorectal Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00337545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*